Stay updated on LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial
Sign up to get notified when there's something new on the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page.

Latest updates to the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry v3.3.2 was added to the history and the previous revision v3.2.0 was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe government funding/status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedNew screenshot shows updated study locations and status indicators for the trial. The list of facilities and participating countries appears expanded or revised compared with the previous version.SummaryDifference0.1%

- Check62 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference9%

- Check70 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.2%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive content changes detected.SummaryDifference0.5%

Stay in the know with updates to LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page.